Braavos Capital

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Wild Bio secures £45m Series A led by the Ellison Institute of Technology to boost crop resilience by learning from wild species

16 Oct 2025

Wild Bio secures £45m Series A led by the Ellison Institute of Technology to boost crop resilience by learning from wild species

Wild Bio applies AI and precision breeding to crop genetics, using insights from wild plant species to develop climate-resilient, higher-yield crop varieties for commercial agriculture.

Braavos Capital

- Life Sciences
1(12 months)
braavos.uk
Update Information

More venture news

Combat Medical
12 Mar 2026
Combat Medical raises a £2.6m Series A led by T&J Meyer Family Foundation for hard-to-treat bladder cancer
Series AHealth
Outpost
10 Mar 2026
Outpost unlocks £13m Series A led by Ribbit for cross-border payments and tax compliance infrastructure
Series AFintech
4 Mar 2026
Shellworks raises £11m Series A led by Alter Equity for biodegradable packaging made from microbial fermentation
Series ASupply Chain

Braavos Capital

Investment Portfolio

Wild Bio secures £45m Series A led by the Ellison Institute of Technology to boost crop resilience by learning from wild species

More venture news

Combat Medical raises a £2.6m Series A led by T&J Meyer Family Foundation for hard-to-treat bladder cancer

Outpost unlocks £13m Series A led by Ribbit for cross-border payments and tax compliance infrastructure

Shellworks raises £11m Series A led by Alter Equity for biodegradable packaging made from microbial fermentation